CCMINC
BIIB icon

Cardinal Capital Management Inc (North Carolina)’s Biogen BIIB Stock Holding History

Cardinal Capital Management Inc (North Carolina)’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-30,467
Closed -$6.57M – 135
2024
Q1 		$6.57M Buy
30,467
+2,845
+10% +$666K 1.07% 34
2023
Q4 		$7.15M Sell
27,622
-8
-0% -$1.97K 1.35% 22
2023
Q3 		$7.1M Buy
27,630
+361
+1% +$96.6K 1.45% 19
2023
Q2 		$7.77M Buy
27,269
+140
+0.5% +$41.7K 1.56% 15
2023
Q1 		$7.54M Sell
27,129
-114
-0.4% -$31.5K 1.57% 15
2022
Q4 		$7.54M Buy
27,243
+3,055
+13% +$863K 1.61% 15
2022
Q3 		$6.46M Sell
24,188
-3,150
-12% -$669K 1.53% 15
2022
Q2 		$5.58M Buy
27,338
+90
+0.3% +$18.4K 1.28% 24
2022
Q1 		$5.74M Buy
27,248
+10,172
+60% +$2.21M 1.16% 31
2021
Q4 		$4.1M Sell
17,076
-420
-2% -$108K 0.81% 46
2021
Q3 		$4.95M Sell
17,496
-59
-0.3% -$19.3K 1.07% 34
2021
Q2 		$6.08M Buy
17,555
+193
+1% +$58.5K 1.28% 29
2021
Q1 		$4.86M Buy
17,362
+375
+2% +$101K 1.07% 35
2020
Q4 		$4.16M Buy
16,987
+245
+1% +$63.2K 0.98% 38
2020
Q3 		$4.75M Buy
16,742
+3
+0% +$837 1.31% 30
2020
Q2 		$4.48M Sell
16,739
-29
-0.2% -$8.72K 1.29% 32
2020
Q1 		$5.3M Buy
16,768
+38
+0.2% +$11.5K 1.75% 12
2019
Q4 		$4.96M Sell
16,730
-224
-1% -$62.2K 1.29% 32
2019
Q3 		$3.95M Sell
16,954
-94
-0.6% -$21.9K 1.09% 41
2019
Q2 		$3.99M Sell
17,048
-174
-1% -$40.2K 1.13% 39
2019
Q1 		$4.07M Sell
17,222
-4
-0% -$1.26K 1.16% 36
2018
Q4 		$5.18M Buy
17,226
+123
+0.7% +$39.3K 1.71% 14
2018
Q3 		$6.04M Sell
17,103
-98
-0.6% -$33.7K 1.71% 13
2018
Q2 		$4.99M Buy
+17,201
New +$4.84M 1.51% 19

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Cardinal Capital Management Inc (North Carolina)'s BIIB Position: Q2 2024 in Review

Cardinal Capital Management Inc (North Carolina) sold out of Biogen (BIIB) in Q2 2024, closing a stake of 30,467 shares — an estimated $6.57M sold.

Cardinal Capital Management Inc (North Carolina) first reported a position in BIIB in Q2 2018 and held it in 24 quarters. The position peaked at $7.77M in Q2 2023. 944 funds tracked by Wall St. Rank hold BIIB as of Q2 2024.

  • Cardinal Capital Management Inc (North Carolina) reported no remaining Biogen position as of Q2 2024 after selling out during the quarter.
  • Cardinal Capital Management Inc (North Carolina) sold 30,467 Biogen shares in Q2 2024, an estimated $6.57M.
  • Cardinal Capital Management Inc (North Carolina) first reported a position in Biogen in Q2 2018 and held it in 24 quarters.
  • Cardinal Capital Management Inc (North Carolina)'s Biogen position peaked at $7.77M in Q2 2023.
  • 944 funds tracked by Wall St. Rank held Biogen as of Q2 2024.

Based on Cardinal Capital Management Inc (North Carolina)'s 13F filing for Q2 2024, filed 12 Jul 2024.